Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. company information, Employees & Contact Information

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.

Company Details

Employees
23
Founded
-
Address
15010 Broschart Road Suite 250, Rockville,md 20850,united States
Phone
717-327-1919
Email
in****@****mix.com
Industry
Biotechnology
HQ
Rockville, MD
Looking for a particular Immunomic Therapeutics, Inc. employee's phone or email?

Immunomic Therapeutics, Inc. Questions

News

Immunomic Therapeutics Reports Positive Results from Its Phase 1 Clinical Trial of ITI-3000 in Patients Diagnosed with Merkel Cell Carcinoma - Business Wire

Immunomic Therapeutics Reports Positive Results from Its Phase 1 Clinical Trial of ITI-3000 in Patients Diagnosed with Merkel Cell Carcinoma Business Wire

Drew Pardoll as a keynote speaker at NFCR’s Global Summit - Oncodaily

Drew Pardoll as a keynote speaker at NFCR’s Global Summit Oncodaily

Not Your “Old School” Immune System - Genetic Engineering and Biotechnology News

Not Your “Old School” Immune System Genetic Engineering and Biotechnology News

Immunomic Therapeutics Appoints Brian Stamper to VP, Cell Therapy Operations - citybiz

Immunomic Therapeutics Appoints Brian Stamper to VP, Cell Therapy Operations citybiz

PharmaJet Partner Immunomic Therapeutics Receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer - FinancialContent

PharmaJet Partner Immunomic Therapeutics Receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer FinancialContent

Immunomic Therapeutics Announces Presentation on Self-amplifying RNA vaccines using the UNITE® platform for Triple-negative Breast Cancer at SITC 39th Annual Meeting 2024 - Business Wire

Immunomic Therapeutics Announces Presentation on Self-amplifying RNA vaccines using the UNITE® platform for Triple-negative Breast Cancer at SITC 39th Annual Meeting 2024 Business Wire

Dendritic Cells and HIV - News-Medical

Dendritic Cells and HIV News-Medical

Top Immunomic Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant